Federal Register notice: FDA seeks comments on an information collection extension for Human Cells, Tissues, and Cellular and Tissue-Based Products: E...
ViiV Healthcare files an NDA for fostemsavir, an investigational, first-in-class attachment inhibitor for treating HIV-1 infection.
Federal Register notice: FDA requests that any industry organizations interested in participating in selecting nonvoting industry representatives to s...
An International Consortium of Investigative Journalists report finds that unlike CDER, CDRH refuses to make public MAUDE data on patients sex, age, a...
FDA authorizes Roche to market its cobas vivoDX MRSA diagnostic test that speeds the detection of MRSA using new technology.
CBER says Chara Biologics is marketing its CharaCore cell product to treat serious diseases and conditions without agency approval.
FDA approves three ANDAs for the first generics of Novartis Gilenya (fingolimod) capsules for treating relapsing forms of multiple sclerosis in adult ...
FDA launches its CURE ID Internet-based repository for reporting experiences using approved drugs in new ways to treat hard-to-treat diseases.